Evidence map›Paper›PMID 40544851›Full record

ArticleThe Lancet. Child & adolescent health2025

Trends and predictions to 2030 in demographic structures and metabolic health for children and adolescents in China: analysis of national school health surveys from 2000 to 2019.

Xinli Song, Bin Zhou, Sarah Baird, Chunling Lu, Zhiying Song, Yi Zhang, Ruolin Wang, Jianuo Jiang, Li Chen, Jieyu Liu and 9 more

Abstract read
In one paragraph

Article in The Lancet. Child & adolescent health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Childhood isolated systolic hypertension is not benign: adult hypertension and cardiovascular remodeling.Hypertension research : official journal of the Japanese Society of Hypertension · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Xinli SongInstitute of Child and Adolescent Health & School of Public Health, Peking University, National Health Commission Key Laboratory of Reproductive Health, Beijing, China.
Bin ZhouSchool of Public Health, Imperial College London, London, UK.
Sarah BairdDepartment of Global Health, Milken Institute School of Public Health, George Washington University, Washington, DC, USA.
Chunling LuDepartment of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA; Division of Global Health Equity, Brigham and Women's Hospital, Boston, MA, USA.
Zhiying SongInstitute of Child and Adolescent Health & School of Public Health, Peking University, National Health Commission Key Laboratory of Reproductive Health, Beijing, China.
Yi ZhangInstitute of Child and Adolescent Health & School of Public Health, Peking University, National Health Commission Key Laboratory of Reproductive Health, Beijing, China.
Ruolin WangInstitute of Child and Adolescent Health & School of Public Health, Peking University, National Health Commission Key Laboratory of Reproductive Health, Beijing, China.
Jianuo JiangInstitute of Child and Adolescent Health & School of Public Health, Peking University, National Health Commission Key Laboratory of Reproductive Health, Beijing, China.
Li ChenInstitute of Child and Adolescent Health & School of Public Health, Peking University, National Health Commission Key Laboratory of Reproductive Health, Beijing, China.
Jieyu LiuInstitute of Child and Adolescent Health & School of Public Health, Peking University, National Health Commission Key Laboratory of Reproductive Health, Beijing, China.
Wen YuanInstitute of Child and Adolescent Health & School of Public Health, Peking University, National Health Commission Key Laboratory of Reproductive Health, Beijing, China.
Yunfei LiuInstitute of Child and Adolescent Health & School of Public Health, Peking University, National Health Commission Key Laboratory of Reproductive Health, Beijing, China.
Jiajia DangInstitute of Child and Adolescent Health & School of Public Health, Peking University, National Health Commission Key Laboratory of Reproductive Health, Beijing, China.
Peijin HuInstitute of Child and Adolescent Health & School of Public Health, Peking University, National Health Commission Key Laboratory of Reproductive Health, Beijing, China.
Jun MaInstitute of Child and Adolescent Health & School of Public Health, Peking University, National Health Commission Key Laboratory of Reproductive Health, Beijing, China.
Yanhui DongInstitute of Child and Adolescent Health & School of Public Health, Peking University, National Health Commission Key Laboratory of Reproductive Health, Beijing, China. Electronic address: dongyanhui@bjmu.edu.cn.
Yi SongInstitute of Child and Adolescent Health & School of Public Health, Peking University, National Health Commission Key Laboratory of Reproductive Health, Beijing, China. Electronic address: songyi@bjmu.edu.cn.
Majid EzzatiSchool of Public Health, Imperial College London, London, UK.
Susan M SawyerCentre for Adolescent Health, Royal Children's Hospital, Parkville, VIC, Australia; University of Melbourne, Faculty of Medicine, Dentistry and Health Sciences, Department of Paediatrics, Parkville, VIC, Australia; Murdoch Children's Research Institute, Parkville, VIC, Australia.

Funding

Medical Research Council MR/V034057/1
6 · The paper itself

Abstract

backgroundUnderstanding the changing metabolic health burden among children and adolescents is crucial for current and future public health resource allocation in China, particularly given rapid population ageing. We aimed to estimate trends in the metabolic burden in children and adolescents aged 7-18 years from 2000 to 2030, using overweight, obesity, and hypertension as proxy indicators.

methodsWe extracted age, sex, height, weight, and blood pressure data for Han children and adolescents aged 7-18 years, as recorded in five cycles of the Chinese National Surveys on Students Constitution and Health in the years 2000, 2005, 2010, 2014, and 2019. We used demographic indicators reported by the Seventh National Population Census in 2020 to represent the demographic situation in 2019 and UN population estimates and projections for China to derive the national age structure from 2000 to 2030. We calculated the 2019 age-standardised prevalence rates of overweight and obesity, hypertension, comorbid overweight and obesity with hypertension, severe obesity, and severe hypertension. Direct standardisation was applied to adjust for the effect of changes in population structures and derive age-specific prevalence estimates from 2000 to 2030. A population development index that captures demographic trends while accounting for the influence of age structure was calculated from birth rate, death rate, and proportions of the population aged 0-14 years and older than 65 years. Correlation coefficients (r) and corresponding p values for the association between the population development index and metabolic burden were calculated with general linear regression models. Multinomial regressions were applied to model age-specific and sex-specific prevalence rates as a function of time. We used decomposition analysis to evaluate the individual contributions of age-specific prevalence, age distribution, and population growth to the net change in case numbers.

findingsThe final analysis of national survey data included 1 106 416 observations. In 2019, the age-standardised prevalence rates were 21·5% (95% CI 21·3-21·7) for overweight and obesity, 16·6% (16·4-16·8) for hypertension, 5·5% (5·4-5·6) for overweight and obesity with hypertension, 1·6% (1·5-1·6) for severe obesity, and 2·1% (2·0-2·2) for severe hypertension. China's population of children and adolescents aged 7-18 years is predicted to decrease from 276 million in 2000 to 181 million in 2030 (-34·4%). Between 2000 and 2030, we estimate increases of 39·0 million (180·6%) cases of overweight and obesity, 7·1 million (131·5%) cases of overweight and obesity with hypertension, 4·3 million (430·0%) cases of severe obesity, and 1·2 million (34·3%) cases of severe hypertension. Between 2000 and 2030, we estimate a slight decrease of 0·3 million (-0·8%) cases of hypertension. A significant negative association between population development index and metabolic burden was observed for 2019 (r=-0·485, p=0·0062) and projected for 2030 (r=-0·417, p=0·020). Decomposition analysis indicated that rising age-specific prevalence is the primary driver of increasing numbers of metabolic cases, partially offset by population decline.

interpretationIn the context of China's declining youth populations, increases in the prevalence, clinical severity, and absolute case numbers of overweight and obesity with hypertension signal a worsening metabolic health burden. Beyond public health policies to shape healthier lifestyle patterns, enhanced efforts are needed to prepare China's primary health-care system and optimise the allocation of paediatric health-care resources.

fundingNational Key R&D Program of China, National Natural Science Foundation of China, Beijing Natural Science Foundation, Peking University Talent Introduction Program Project, Clinical Medicine Plus X-Young Scholars Project of Peking University, UK Medical Research Council, and the Abdul Latif Jameel Institute for Disease and Emergency Analytics at Imperial College London, funded by a donation from Community Jameel.

Indexed as

HypertensionPediatric ObesityAdolescentChildChinaFemaleHealth SurveysHumansMaleOverweightPrevalence

Identifiers

PMID40544851
PMCPMC7617964

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.